NCT01608217View on ClinicalTrials.gov

Delta-THC in Dementia

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Behavioural DisturbancesPainDementiaAlzheimer's DementiaVascular Dementia
Interventions
DRUG

delta-9-tetrahydrocannabinol (delta-THC)

delta-THC 1.5 mg (tablet)three times daily for a period of 3 weeks.

DRUG

Placebo

placebo (tablet) three times daily for a period of three weeks.

DRUG

Acetaminophen

Acetaminophen 1000 mg three times daily for a period of 3 weeks

DRUG

Acetaminophen

Acetaminophen 1000 mg three times daily for a period of three weeks

Trial Locations (2)

5912

Vincent van Gogh Institute for Psychiatry, department of Elderly, Venlo

6525

Radboud university medical center, department of Geriatrics, Nijmegen

All Listed Sponsors
collaborator

Health Valley, Netherlands

NETWORK

lead

Radboud University Medical Center

OTHER

NCT01608217 - Delta-THC in Dementia | Biotech Hunter | Biotech Hunter